Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
231 Leser
Artikel bewerten:
(1)

Alison AI: Alison.ai Secures $13M in Seed Funding to Expand AI-Driven Creative Solutions

Finanznachrichten News

WILMINGTON, DE / ACCESSWIRE / November 12, 2024 / Alison Technologies Ltd (Alison.ai), a trailblazer in creative AI solutions for advertising, today announced the successful closing of a $13.3 million Seed funding round. The round was led by Almaz Capital, with participation from Foresight Group, Cardumen Capital, Crescendo Venture Partners, and Alumni Ventures.

Image Credit: Alison AI

The newly raised funds will be instrumental in Alison.ai's strategic expansion furthering its expansion in the US and Western European markets. The company also aims to strengthen and improve its innovative video creation capabilities and broaden its value proposition with additional products. These initiatives will further expand Alison.ai's addressable market and enhance the integration of Alison.ai's solutions across more teams within their client companies.

The advertising and marketing industry faces significant challenges, with advertisers often seeing large budgets wasted on ineffective ads due to unnecessary tests (such as A/B testing) and on high production costs. According to Digiday's State of Dynamic Advertising report, 40% of agencies are "leveraging data-driven content variations" for their dynamic creative optimization, yet only 20% are "incorporating AI-powered tools into their workflows," leaving room for inefficiency in creative analysis and campaign optimization. Alison.ai addresses these pain points by leveraging advanced AI to generate full video creatives using both their customers' data and data gleaned from their competitors' creatives. Alison.ai's technology helps advertisers reach the exact advertisement that will yield the best results without performing unnecessary tests and with minimal production costs. Alison.ai improves return on advertising spend (ROAS) threefold, increases click-through rates (CTR) by 200%, and cuts production and test budgets by about 50% on average.

Founded in 2021 by Asaf Yanai (CEO) and Koby Berkovich (CTO), Alison.ai has quickly established itself as a leader in the AI-driven advertising sector. The company's unique platform allows advertisers to eliminate the need for iterative testing and experimentation cycles and instead, cut through directly to the generation of optimized final scripts, storyboards, and full video creatives, setting a new standard in the industry. With presence in the USA, UK, Israel, and Ukraine, the company employs a diverse team of 50 dedicated professionals. Its prominent customers include LG, Bosch, Ferrara Candy Company, HelloFresh, Warner Brothers, Zynga, TikTok, P&G, and Desigual.

"At Alison.ai, we believe in the transformative power of AI to reshape the world of advertising. This investment will enable us to push the boundaries of what's possible and deliver even greater value to our clients around the world. We're looking forward to continuing our journey of growth and innovation and are eager to see the incredible impact our enhanced capabilities will bring to the advertising industry," shared Alison.ai CEO and Co-founder Asaf Yanai.

General Partner at Almaz Capital, Yoav Samet, expressed strong confidence in Alison.ai, stating "We are thrilled to lead this investment round in Alison.ai. The company's unique application of AI in the creative content development process has the potential to revolutionize how businesses generate content at orders of magnitude faster speed and lower cost. We are confident that Alison.ai will be a major player in the future of AI-powered content creation."

Gonzalo Martínez De Azagra, Founder and General Partner at Cardumen Capital, added, "We are excited to continue our support for Alison.ai as the company enters this new phase of growth. The company's team has made significant progress in developing its creative optimization and generation solution, and we are confident that they will continue to execute their vision."

"Alison.ai is a company that we have believed in since its inception. We are impressed with the progress the company has made and are excited to be a part of its continued success," commented Yuval Avni, Managing General Partner at Crescendo Venture Partners.

For further information, please contact:

Media Enquiries:

Omri Hurwitz
E: omri@omrihuwitz.com
P: +972 52-581-7666

About Alison Technologies Ltd.

Alison.ai is dedicated to transforming how businesses approach creativity in advertising. Harnessing the power of creative AI, Alison.ai empowers marketers to make informed decisions, generate better-performing creatives, enhance campaign performance, and stay ahead of the competition. Alison.ai is the first and only company in the world to allow advertisers to generate full video creatives based on their data as well as that of their competitors.

To learn more about Alison.ai, visit https://alison.ai/

SOURCE: Alison AI



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.